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ABSTRACT: Sensorineural hearing loss (SNHL) is
one of the most common congenital disorders in humans,
afflicting one in every thousand newborns. The majority
is of heritable origin and can be divided in syndromic
and nonsyndromic forms. Knowledge of the expression
profile of affected genes in the human fetal cochlea is lim-
ited, and as many of the gene mutations causing SNHL
likely affect the stria vascularis or cochlear potassium
homeostasis (both essential to hearing), a better insight
into the embryological development of this organ is
needed to understand SNHL etiologies. We present an
investigation on the development of the stria vascularis in
the human fetal cochlea between 9 and 18 weeks of gesta-
tion (W9–W18) and show the cochlear expression
dynamics of key potassium-regulating proteins. At W12,
MITF1/SOX101/KIT1 neural-crest-derived melano-
cytes migrated into the cochlea and penetrated the base-
ment membrane of the lateral wall epithelium,
developing into the intermediate cells of the stria vascula-
ris. These melanocytes tightly integrated with Na1/K1-
ATPase-positive marginal cells, which started to express
KCNQ1 in their apical membrane at W16. At W18,
KCNJ10 and gap junction proteins GJB2/CX26 and
GJB6/CX30 were expressed in the cells in the outer sul-
cus, but not in the spiral ligament. Finally, we investi-
gated GJA1/CX43 and GJE1/CX23 expression, and
suggest that GJE1 presents a potential new SNHL associ-
ated locus. Our study helps to better understand human
cochlear development, provides more insight into multi-
ple forms of hereditary SNHL, and suggests that human
hearing does not commence before the third trimester of
pregnancy. VC 2015 Wiley Periodicals, Inc. Develop Neurobiol 75:
1219–1240, 2015
Keywords: human; sensorineural hearing loss; develop-
ment; stria vascularis; melanocytes
INTRODUCTION
According to recent estimates of the World Health
Organization, more than 5% of the world’s total pop-
ulation suffer from some form of disabling hearing
loss (WHO, 2014). A large part of this hearing loss is
of sensorineural nature, making sensorineural hearing
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loss (SNHL) the most prevalent sensorineural disor-
der in humans. SNHL is also the most common con-
genital disorder, with a prevalence of 1 in every 1000
newborns in the UK and the Netherlands (with a
bilateral hearing loss 40 dB (NHSP, 2011; van der
Ploeg et al., 2012)). Of these, over two-thirds can be
attributed to genetic factors. Hereditary SNHL can be
classified in syndromic (25%) and nonsyndromic
(75%) forms (Morton and Nance, 2006).
Examples of syndromic SNHL include Pendred’s
syndrome ([MIM 274600, www.omim.org/], combin-
ing hearing loss and goiter (Pendred, 1896; Bizha-
nova and Kopp, 2010)), Waardenburg syndrome
[WS; hearing loss and pigmentation abnormalities
(Waardenburg, 1951; Pingault et al., 2010)] and Jer-
vell and Lange-Nielsen syndrome ([MIM 220400 and
MIM 612347], hearing loss and cardiac symptoms
(Jervell and Lange-Nielsen, 1957)). In nonsyndromic
SNHL, associations with obvious abnormalities of
the external ear or symptoms other than hearing loss
cannot be found, but the heterogeneity of loci and
genes is high: over 130 loci have been mapped and
over 60 different genes have been implicated pres-
ently (van Camp and Smith). Nonsyndromic forms
are grouped in autosomal dominant (DFNA), autoso-
mal recessive (DFNB), X-linked (DNFX) and mitro-
chondrial subtypes. The most commonly affected
gene causing nonsyndromic hearing loss (both in
autosomal recessive DFNB1A [MIM 220290] and in
autosomal dominant DFNA3A [MIM 601544]) is gap
junction beta 2 (GJB2, [MIM 121011]), the gene
encoding the connexin 26 protein (CX26) (Kelsell
et al., 1997; Denoyelle et al., 1997). Depending on
the studied population, 20–50% of all recessive non-
syndromic SNHL cases can be attributed to a muta-
tion in GJB2 (Hilgert et al., 2009a; Linden Phillips
et al., 2013). For a comprehensive overview of other
affected genes, we refer to recent reviews (Hilgert
et al., 2009b; Angeli et al., 2012; Shearer and Smith,
2012; Smith et al., 2014; Stelma and Bhutta, 2014).
In SNHL, the disorder lies either in the cochlea
itself or in any of the retrocochlear auditory struc-
tures. Cochlear hair cells are responsible for convert-
ing sound into electrical signals that travel to the
brainstem via the cochlear nerve (Hudspeth, 1989).
Hair cell function depends on the endocochlear poten-
tial, a positive extracellular potential (80–100 mV
relative to perilymph) in the endolymph of the coch-
lear duct (or scala media), generated by an unusually
high concentration of potassium ions (K1) (Smith
et al., 1954). These ions are secreted into the endo-
lymph by specialized cells within the stria vascularis,
located in the lateral wall of the cochlear duct
(Patuzzi, 2011). The stria vascularis is highly vascu-
larized and consists of three layers of distinct cell
types: the marginal cells, the intermediate cells (mela-
nocytes), and the basal cells (Kimura and Schuknecht,
1970; Hilding and Ginzberg, 1977). It is generally
accepted that the depolarizing K1 flow causing hair
cell activation in the organ of Corti is recycled back
to the stria vascularis via the epithelial lining of the
cochlear duct and the spiral ligament fibrocytes, and/
or through the perilymph, as depicted in Figure 1. To
maintain the endocochlear potential, this recycling
system requires a specific distribution of cochlear cell
types as well as selective ion channels and gap-
junctions (Zdebik et al., 2009; Adachi et al., 2013).
Therefore, it is not surprising that many gene
mutations causing SNHL either result in functional
changes of the ion channels involved in K1 homeo-
stasis or cause an abnormal cellular morphology in
the cochlea. Although progress has been made in
identifying the genes responsible for SNHL in
humans, knowledge on their actual expression in the
human cochlea is limited and only a few studies have
investigated the morphological development of the
stria vascularis in the human fetal cochlea (Lavigne-
Rebillard and Bagger-Sj€ob€ack, 1992; Bibas et al.,
2000). In this article, we address both aspects, focus-
sing on the embryonic development of the lateral
wall in the human fetal cochlea. We show the expres-
sion profiles of several genes involved in syndromic
and nonsyndromic SNHL (Table 1) between 9 and 18
weeks of gestation (W9–W18). More specifically, we
have investigated the development of the different
cell types in the stria vascularis and studied the
expression of K1-regulating and gap junction pro-
teins. Together, our data give insight in hereditary
SNHL and provide a basis for K1-recycling models
in the human cochlea.
METHODS
Tissue Samples
Human fetal cochleas were collected from tissues obtained
by elective abortion (healthy subjects, no medical indica-
tion) using vacuum aspiration. Prior to the procedure,
obstetric ultrasonography was used to determine the gesta-
tional age in weeks and days. Of all collected cochleas, we
discarded those which where mechanically damaged or
showed marked tissue degeneration, upon inspection by
light-microscopy. Cochleas of the following gestational
ages were collected and used: W9, W9.1, W10.4 (23),
W12 (23), W12.2, W14 (23), W16 (23), W18 (33). The
cochleas were obtained in PBS, fixed in 4% paraformalde-
hyde in PBS overnight at 4C, decalcified and embedded in
paraffin as previously described (Locher et al., 2013). The
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use of human fetal material was approved by the Medical
Ethical Committee of the Leiden University Medical Cen-
ter (protocol 08.087). Informed written consent was
obtained in accordance with the WMA Declaration of Hel-
sinki guidelines.
Immunohistochemistry
The cochleas were cut in 5 or 10 lm thick sections in the
sagittal plane using a RM2255 microtome (Leica). Deparaf-
finization and immunohistochemistry were carried out as
previously described (Locher et al., 2013). Briefly, antigen
retrieval was performed (see below) and sections were con-
secutively incubated with primary and secondary antibodies
diluted in blocking solution consisting of 1% bovine serum
albumin (Sigma-Aldrich) and 0.05% Tween-20 (Promega)
in PBS. Nuclei were stained with 40,6-diamidino-2-phenyl-
indole (DAPI, Vector Laboratories). The primary antibod-
ies used in this study were mouse anti-acetylated tubulin
(aceTUBA, 1:500, T6793, Sigma), rabbit anti-collagen type
IV (COL4, 1:200, AB748, Chemicon), rabbit anti-
fibronectin (FN, 1:400, F3648, Sigma-Aldrich), rabbit anti-
GJA1 (1:1000, C6219, Sigma), rabbit anti-GJA1 (1:2000,
ACC-201, Alomone labs), rabbit anti-GJB2 (1:100,
ACC-212, Alomone labs), rabbit anti-GJB6 (1:100,
PA511640, Thermo Scientific), rabbit anti-GJE1 (1:1000,
NBP2–14051, Novus biologicals), goat anti-KCNJ10
(1:100, NBP1–70371), rabbit anti-KCNQ1 (1:200,
ab65092, Abcam), rabbit anti-KCNQ1 (1:100, APC-022,
Alomone labs), rabbit anti-KIT (1:100, A4502, Dako), rab-
bit anti-laminin (LAM, 1:200, Z009701, Dako), rabbit anti-
melan-A (1:500, NBP1–30151, Novus), mouse anti-
microphthalmia-associated transcription factor (MITF,
1:100, M3621, Dako), mouse anti-Na1/K1-ATPase a1
(ATP1A1, 1:200, a6F, Developmental Studies Hybridoma
Bank), rabbit anti-solute family carrier 2, member 1
(SLC2A1, 1:500, ab15309, Abcam), and goat anti-SOX10
(1:50, sc-17342, Santa Cruz Biotechnology). Prior to
immunostaining for COL4, LAM, and FN antibodies, anti-
gen retrieval was performed by incubating sections for 5
min with 20 mg/mL proteinase K (Promega) in Tris-EDTA-
CaCl2 buffer (pH8.0). In all other cases, tissue sections
were treated for 12 min at 97C with 0.01 M sodium citrate
buffer (pH 6.0) and allowed to cool down. The secondary
antibodies used were Alexa Fluor (AF) conjugated immu-
noglobulins (Life Technologies): AF 488 donkey anti-
mouse (A-21202), AF 488 donkey anti-rabbit (A-21206),
AF 488 donkey anti-goat (A-11055), AF 568 donkey anti-
mouse (A-10037), and AF 568 donkey anti-rabbit (A-
10042), all at a 1:500 dilution. As antibody specificity con-
trols, primary antibodies were routinely omitted (negative
control), isotype controls were performed (negative con-
trol), and immunostainings were performed on adult mouse
cochlea (positive control). On human fetal tissue, at least
three separate immunostaining experiments were per-
formed with each primary antibody. To further verify speci-
ficity, all immunostaining results were checked to confirm
the appropriate cellular location of the fluorescent signals
Figure 1 Capturing cochlear potassium homeostasis in
mammals. (A) A schematic illustration of a cross-section
through the adult cochlea. The cochlear duct (or scala
media) is filled with endolymph containing a high [K1]
that is maintained by the stria vascularis. Potassium recy-
cling is postulated to either occur via the supporting cells of
the organ of Corti and the epithelial lining of the outer sul-
cus (Claudius cells and root cells), or through the perilymph
of the scala tympani. (B) A schematic anatomical (upper
half) and compartmental (lower half) model of the adult
stria vascularis showing the three cellular layers and depict-
ing the location of potassium regulating channels. The stria
vascularis is electrochemically isolated from neighboring
structures by tight junctions (black bars). [Color figure can
be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
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and tissue expression patterns were compared to previous
studies using experimental animals, if available.
Image Acquisition and Processing
Confocal images were acquired with a Leica SP8 confocal
laser scanning microscope operating under the Leica Appli-
cation Suite Advanced Fluorescence software (LAS AF)
using Leica objectives (403/1.3 oil HC PL Apo or 633/1.4
oil HC PL Apo). Maximal projections were obtained from
image stacks with a z-step size of 0.5 lm. Brightness and
contrast adjustments consistent with image manipulation
policies were performed either with LAS AF, Fiji (ImageJ
version 1.48k (Schindelin et al., 2012)) or Adobe Photo-
shop CS6 (Adobe Systems) image-processing software.
RESULTS
Melanocytes Invade the Lateral Wall
Epithelium at W12 and Develop into the
Intermediate Cells
The cochlear melanocytes that form the intermediate
cell layer of the stria vascularis are thought to origi-
nate from the neural crest. To investigate the forma-
tion of the three cell layers of the stria vascularis, we
first determined the cochlear location of melanocytes
and monitored their invasion into the lateral wall epi-
thelium during embryonic development of the human
fetal cochlea. Immunostaining for melan-A ([MIM
605313], a marker of melanocytes) and acetylated a-
tubulin (aceTUBA, which labels various types of epi-
thelial and neural cells) allowed us to visualize mela-
nocyte location and general cochlear architecture. At
W9.1, the melan-A1 melanocytes were located both
in the part of the periotic mesenchyme that will
develop into the otic capsule (called hereafter: otic
capsule), and in the part of the periotic mesenchyme
that will form the spiral ligament and the spiral lim-
bus (called hereafter: periotic mesenchyme) but not
in the epithelium of the cochlear duct [Fig. 2(A,B),
Supporting Information Figure S1]. More specifi-
cally, most melanocytes were found in the apical half
of the developing cochlea situated above the cochlear
duct, and only a few could be observed in the periotic
mesenchyme bordering the lateral wall epithelium,
that is, the future stria vascularis [Fig. 2(B), right
arrowhead]. Immunostaining for basement membrane
proteins LAM (Supporting Information Figure S2A),
COL4 (Supporting Information Figure S2B), and FN
(Supporting Information Figure S2C) at W9.4
showed a strictly continuous and smooth basement
membrane, further confirming the mesenchymal loca-
tion of the melanocytes. At W10.4, the cochlear duct
Table 1 Selected Genes and Association with Syndromic and Nonsyndromic Sensorineural Hearing Loss
Gene MIM SNHL in Genetic Disorder (MIM)
MITF 156845 Waardenburg syndrome, type 2A (193510)
Waardenburg syndrome/ocular albinism, digenic (103470)
Tietz albinism-deafness syndrome (103500)
SOX10 602229 Waardenburg syndrome, type 4C (613266)
Waardenburg syndrome, type 2E (611584)
PCWH syndrome (609136)
Kallman syndrome with deafness (not defined)
KIT 164920 Piebaldism (172800)
KCNQ1 (KVLQT1) 607542 Jervell and Lange-Nielsen syndrome (220400)
KCNJ10 (Kir4.1) 602208 Enlarged vestibular aqueduct, digenic (600791)
SESAME syndrome (612780)
GJB2 (CX26) 121011 DFNA3A (601544)
DFNB1A (220290)
Hystrix-like ichthyosis with deafness (602540)
Keratitis-ichthyosis-deafness syndrome (148210)
Bart-Pumphrey syndrome (149200)
Keratoderma, palmoplantar, with deafness (148350)
Vohwinkel syndrome (124500)
GJB6 (CX30) 604418 DFNA3B (612643)
DFNB1B (612645)
DFNB1A, digenic (220290)
GJA1 (CX43) 121014 DFN not defined
GJE1 (CX23) Not defined Unknown
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Figure 2 Migration of melanocytes into the stria vascularis of the human fetal cochlea. (A-B) A
cochlea at W9.1 immunostained for acetylated tubulin (aceTUBA; red), melan-A (green) and DAPI
(blue) (A) or melan-A (green) and DAPI (blue) (B). Arrowheads point to melan-A1 cochlear mela-
nocytes. Scale bars5 50 mm. (C) The lower middle turn (M1) of a cochlea at W10.4 immuno-
stained for aceTUBA (red), melan-A (green), and DAPI (blue). Scale bar5 50 mm. (D) The lower
basal turn (B1) of a cochlea at W10.4 immunostained for aceTUBA (red), melan-A (green), and
DAPI (blue). Scale bar5 50 mm. (E) The apical and lower middle turn of cochlea at W12 immuno-
stained for aceTUBA (red), melan-A (green), and DAPI (blue). Scale bar5 50 mm. (F-F0) The
lower basal turn of a cochlea at W12.2 immunostained for aceTUBA (red), melan-A (green), and
DAPI (blue). The melan-A signal is shown separately in white in (F0). Scale bar5 50 mm. (G).
Higher magnification of the outlined area in (F). Arrowheads point to melan-A1 melanocytes
located in the periotic mesenchyme. Arrows point to melan-A1 melanocytes located in between
the epithelial lining of the cochlear duct lateral wall (the future marginal cells of the stria vascula-
ris). Scale bar5 20 mm. (H-H0). A similar section of the lower basal turn of a cochlea at W12.2 as
depicted in (F), here immunostained for basement membrane protein laminin (LAM). The LAM
signal is shown separately in white in (H0). Scale bar5 50 mm. (I-I0) Higher magnification of the
developing stria vascularis outlined in (H). The arrowheads point to the smooth and continuous
appearance of the basement membrane at the location of the bordering Reissner’s membrane and
the outer sulcus, as opposed to the irregular pattern observed in at the location of the future stria
vascularis. The LAM signal is shown separately in white in (I0) Scale bar5 20 mm. [Color figure
can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
had spiralled twice around the central axis of the
cochlea and melan-A1 melanocytes were observed
exclusively in the periotic mesenchyme of the future
middle and basal turns [Fig. 2(C,D), arrowheads].
When compared to W9.1, more melanocytes were
located close to the lateral wall epithelium.
At W12, melan-A1 melanocytes were observed in
all cochlear turns. In the apical and middle turns, mela-
nocytes were still located exclusively to the periotic
mesenchyme [Fig. 2(E)]. However, in the basal turn,
melanocytes were observed both in the periotic mesen-
chyme [Fig. 2(F) and arrowheads in Fig. 2(G)] and in
the lateral wall epithelium of the cochlear duct (the
future stria vascularis), indicating that they had pene-
trated through the basement membrane [arrows in Fig.
2(G)]. This finding is in agreement with the observation
that the basement membrane at this location showed
irregular staining patterns for LAM, COL4, and FN, in
contrast to its smooth and continuous appearance near
the developing Reissner’s membrane and at the location
of the outer sulcus [Fig. 2(H,I) and three-dimensional
reconstruction provided in Interactive PDF file 1].
Melanocytes in the Stria Vascularis
Express MITF, SOX10, and KIT
Next, we investigated the expression of two genes,
MITF [MIM 156845] and SOX10 [MIM 602229] that
are expressed in the melanocytic lineage. At W12,
MITF was expressed in all turns in both the melan-
A1 melanocytes in the periotic mesenchyme and in
the melanocytes that had invaded the developing stria
vascularis [Fig. 3(A)]. Previously, we have shown
that SOX101 cells are present in the spiral ganglion
and throughout the cochlear epithelium (Locher
et al., 2014). In this study, we also detected SOX10
expression in the presumptive melanocytes bordering
the stria vascularis [Fig. 3(B), arrowheads].
Double immunostaining for MITF and KIT [MIM
164920], the latter protein being expressed in both
the neural crest and the melanocytic lineage, at W12
showed that KIT was expressed by all MITF1 mela-
nocytes [Fig. 3(C)]. In addition, KIT expression was
found in the cochlear duct epithelium, in a few
remaining mesenchymal cells within the developing
scala tympani [Fig. 3(C,D)], and in the spiral gan-
glion (data not shown).
In the Developing Stria Vascularis,
Melanocytes Integrate with the Marginal
Cells in a Spatiotemporal Order
At W12, we detected a clear spatial gradient in the
location of melanocytes, with epithelial invasion
commencing in the basal turn [Fig. 2(E,F)]. To moni-
tor this development, we immunostained cochleas at
W14, W16, and W18 for melan-A and aceTUBA. At
W14, melan-A1 melanocytes were still confined to
the periotic mesenchyme in both the upper middle
(M2) and lower middle (M1) turns [Fig. 4(A,B)]. In
the upper basal turn (B2), melanocytes were observed
invading the lateral wall epithelium [Fig. 4(C)] and
in the lower basal turn (B1) most melanocytes were
found integrating with the developing marginal cells
[Fig. 4(D)]. At W16, integrating melanocytes were
found in greater numbers and observed throughout all
turns [Fig. 4(E–H)]. In addition to melanocytes in or
near the lateral wall epithelium, we also consistently
observed the presence of melan-A1 melanocytes
along the edges of the otic capsule, here shown in the
M2 turn at W16 [Fig. 4(I), arrowheads] and the B1
turn at W18 [Fig. 4(J), arrowheads]. At W18, mela-
nocytes were found tightly integrated with the devel-
oping marginal cells in the B1 turn, and some
melanocyte processes were also observed around the
developing strial capillaries [Fig. 4(K), arrowheads].
Expression patterns of aceTUBA [Fig. 4(K)] and the
basement membrane proteins LAM, COL4, and FN
better accentuated the development of other regions
in the lateral wall epithelium [Fig. 4(L–N), Support-
ing Information Figure S2D-L and Supporting Infor-
mation Figure S3, and three-dimensional
reconstruction provided in Interactive PDF files 2 and
3]. In particular, with these immunostainings the spi-
ral prominence is clearly emerging, thereby demar-
cating the stria vascularis from the future root cells in
the outer at W18.
Until W18, SLC2A11 Basal Cells Were
Not Detected in the Stria Vascularis
In the stria vascularis, in addition to the marginal cells
and the melanocytes, we also investigated the forma-
tion of the third and innermost strial layer, that is, the
basal cells. However, until W18, we were unable to
detect any basal cells by immunostaining for solute
family carrier 2, member 1 (SLC2A1, also known as
GLUT1, [MIM 138140]), a glucose transporter known
to be expressed by the rodent cochlear basal cells and
vascular endothelial cells (Ito et al., 1993). SLC2A1
expression was found in the developing human stria
vascularis but this expression was confined to capilla-
ries and erythrocytes (Supporting Information Figure
S4). Interestingly, we did observe consistent expres-
sion of SLC2A1 on the apical (luminal) membranes of
all epithelial cells between the organ of Corti and the
spiral prominence (Hensen’s cells in the organ of Corti
as well as Claudius’ cells and root cells in the outer
1224 Locher et al.
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sulcus) at all studied stages (from W12 to W18, Sup-
porting Information Figure S4).
Dynamics of KCNQ1 in the Developing
Human Cochlear Duct
To investigate the onset of expression and develop-
mental distribution of ion channels and enzymes
involved in cochlear K1 transport and the generation
of the endocochlear potential, we immunostained for
the K1 channel protein KCNQ1 [MIM 607542]. At
W10.4 [Fig. 5(A)] and W12.2 [Fig. 5(B)], reactivity
was observed at the basement membrane delineating
the lateral wall epithelium. At W14, this pattern had
changed to reactivity in the developing Reissner’s
membrane [arrowhead in Fig. 5(C)] and the future
outer sulcus [arrow in Fig. 5(C)]. From W16 [Fig.
5(D,F)] to W18 [Fig. 5(H,I)] increased KCNQ1
expression was observed at the apical (luminal) mem-
brane of the developing marginal cells in the stria
vascularis, in addition to reactivity in Reissner’s
membrane [Fig. 5(E,H)] and the future root cells of
the outer sulcus [Fig. 5(G,J)]. However, a different
anti-KCNQ1 antibody clone (Alomone) that also rec-
ognizes the C-terminus of KCNQ1 did not show any
reactivity in Reissner’s membrane or in the root cells
of the outer sulcus. It did, however, show identical
reactivity in the developing marginal cells at W16
and W18 (data not shown). Although we cannot
explain this difference as both antibodies should rec-
ognize the same KCNQ1 transcript, expression of
KCNQ1 in Reissner’s membrane has been reported
previously (Kim et al., 2009).
Dynamics of Na1/K2–ATPase in the
Developing Cochlear Duct
Already at W10.4, immunostaining for the alpha-1 sub-
unit of Na1/K1-ATPase (ATP1A1, [MIM 182310])
was observed in different degrees throughout the entire
epithelium of the cochlear duct, with a moderate inten-
sity in the future stria vascularis [Fig. 6(A)]. However,
at W12 ATP1A1 expression increased in the developing
stria vascularis on the basolateral membranes of the
developing marginal cells [Fig. 6(B)]. At W14 and
W16, ATPA1 expression became even more prominent
and was located in cells adjacent to the increasing num-
bers of invading melan-A1 melanocytes [Fig. 6(C–E)].
Immunostaining diminished in most parts of the epithe-
lium, and at W18 ATP1A1 expression was found on the
basolateral membranes of the marginal cells, on the
basolateral membranes of the developing hair cells in
the organ of Corti, as well as on both the apical and
basolateral membranes of the Claudius’ cells and the
root cells in the outer sulcus [Fig. 6(F–H)]. Curiously, at
this stage, pillar cells in the organ of Corti were also
consistently found to stain positive for melan-A in the
basal turn, although these are not of melanocytic origin
[Fig. 6(G)]. Focusing on the stria vascularis, we found
melan-A1 melanocyte processes penetrating between
the marginal cells toward the lumen of the cochlear duct
[Fig. 6(I), arrow]. We also observed ATP1A1 expres-
sion around the melan-A1 melanocyte cell bodies [Fig.
6(I), arrowhead] and around melanocyte processes
encircling the strial capillaries [Fig. 6(J), arrows].
KCNJ10 Expression Is Confined to the
Outer Sulcus at W18
From W16 onward, we observed KCNJ10 in the
future root cells cells of the outer sulcus (Fig. 7).
However, we did not observe KCNJ10 expression by
strial melanocytes at any of the investigated stages
(data not shown).
Distribution of GJB2, GJB6, GJA1, and
GJE1 in the Human Fetal Cochlea
To investigated the developmental expression of gap
junction proteins, we immunostained for GJB2 (CX26),
Figure 3 Expression of MITF, SOX10 and KIT. (A) Lateral wall area of the lower basal turn of a
cochlea at W12 immunostained for microphthalmia-associated transcription factor (MITF) (red),
melan-A (green), and DAPI (blue), showing Melan-A1/MITF1 melanocytes in the periotic mes-
enchyme as well as in the developing stria vascularis. Signals are shown separately in white. Scale
bar5 20 mm. (B) Lateral wall area of the lower basal turn of a cochlea at W12 immunostained for
SOX10 (green) and DAPI (blue). Signals are shown separately in white. Arrowheads point to
SOX101 melanocytes located in the periotic mesenchyme. Scale bar5 20 mm. (C) Lateral wall
area of the lower basal turn of a cochlea at W12 immunostained for MITF (red), KIT (green), and
DAPI (blue), showing KIT1/MITF1 melanocytes in the periotic mesenchyme as well as in the
developing stria vascularis. Signals are shown separately in white. Scale bar5 100 mm. (D) The
lower basal turn of a cochlea at W12 immunostained for KIT (green) and DAPI (blue). The KIT
signal is shown separately in white. The arrowhead points to KIT1 melanocytes in the periotic
mesenchyme next to the developing stria vascularis. #5Tissue artifact. Scale bar5 20 mm. [Color
figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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GJB6 (CX30, [MIM 604418]), GJA1 (CX43 [MIM
121014]), all known to be expressed in the human
cochlea (Kammen-Jolly et al., 2001; Liu et al., 2009;
Liu et al., 2013), and GJE1 (CX23 [MIM unknown]),
which expression pattern has not been investigated pre-
viously in the cochlea (see Discussion).
Figure 4 Maturation of the lateral wall in the human fetal cochlea. (A–D) Lateral wall area of the
upper middle [M2, (A)], lower middle [M1, (B)], upper basal [B2, (C)], and lower basal [B1, (D)]
turn of a cochlea at W14 immunostained for acetylated tubulin (aceTUBA; red), melan-A (green),
and DAPI (blue). Scale bars5 20 mm. (E-H) Lateral wall area of the upper middle (E), lower mid-
dle (F), upper basal (G), and lower basal (H) turn of a cochlea at W16 immunostained for aceTUBA
(red), melan-A (green), and DAPI (blue). Scale bars5 20 mm. (I) The upper middle turn of a coch-
lea at W16 immunostained for aceTUBA (red), melan-A (green), and DAPI (blue). Arrowheads
point to melan-A1 melanocytes located in the periotic mesenchyme at the edges of the otic cap-
sule. Scale bar5 100 mm. (J) The lower basal turn of a cochlea at W18 immunostained for melan-
A (green) and DAPI (blue). Arrowheads point to melan-A1 melanocytes located in the periotic
mesenchyme at the edges of the otic capsule. st5 scala tympani. Scale bar5 100 mm. (K) The
lower basal turn of a cochlea at W18 immunostained for aceTUBA (red), melan-A (green), and
DAPI (blue). Arrowheads point to melan-A positive strial melanocytes around developing strial
capillaries. Scale bar5 20 mm. (L–N) The lower basal turn of a cochlea at W18 immunostained for
basement membrane proteins laminin (LAM) (L, green), collagen type IV (COL4) (M, green) and
fibronectin (FN) (N, green), and DAPI (blue). Scale bars5 20 mm. [Color figure can be viewed in
the online issue, which is available at wileyonlinelibrary.com.]
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Throughout the investigated stages (W10.4–
W18), the GJB2 and GJB6 expression patterns
remained identical to each other (Fig. 8). At
W10, immunostaining for GJB2 and for GJB6
showed a diffuse and punctated pattern in both
Kolliker’s organ and the cells of the future outer
sulcus [Fig. 8(A,B)]. By W12, expression of
GJB2 and GJB6 had greatly increased and could
clearly be observed on both sides of the develop-
ing organ of Corti [Fig. 8(C,D)]. In the subse-
quent weeks, up to W18, this pattern remained
consistent as both in the K€olliker’s organ and in
the cells lining the outer sulcus (Claudius’ cells
and future root cells) expression of GJB2 and
GJB6 was observed [Fig. 8(E–J)]. Although
expression of both GJB2 and GJB6 has been
reported in the spiral ligament fibrocytes in the
adult human cochlea (Liu et al., 2009), no expres-
sion could be observed in these cells at least up
to W18 [Fig. 8(J)]. We also did not detect expres-
sion in the organ of Corti itself.
Immunostaining for GJA1 showed weak expres-
sion by a significant subgroup of spiral ligament
fibrocytes at W14 [Fig. 9(A)]. In the subsequent
weeks, this expression became more prominent and
at W18 could be clearly defined as belonging to the
type I fibrocytes [Fig. 9(B,C)].
Immunostaining for GJE1 revealed a dynamic pat-
tern of expression during human cochlear develop-
ment. At W10.4 and W12, strong expression of GJE1
was observed in the basolateral membranes of the
future marginal cells [Fig. 10(A,B)]. Interestingly, at
W14, expression was observed both in the lateral
wall epithelium and in some of the cells in the adja-
cent periotic mesenchyme, presumably melanocytes
[Fig. 10(C)]. At W16, expression of GJE1 was
Figure 5 KCNQ1 expression in the human fetal cochlea. (A-A0) The lower basal turn of a cochlea
at W10.4 immunostained for acetylated tubulin (aceTUBA) (red), voltage-gated potassium channel
KCNQ1 (green), and DAPI (blue). The KCNQ1 signal is shown separately in white in (A0). Scale
bar5 50 mm. (B-B0) The lower basal turn of a cochlea at W12.2 immunostained for aceTUBA
(red), KCNQ1 (green), and DAPI (blue). The KCNQ1 signal is shown separately in white in (B0).
Scale bar5 50 mm. (C-C0) The lower basal turn of a cochlea at W14 immunostained for aceTUBA
(red), KCNQ1 (green), and DAPI (blue). The KCNQ1 signal is shown separately in (C0). The
arrowhead points at KCNQ1 signals in the developing Reissner’s membrane, the arrow points at
KCNQ1 signals at the location of the future root cells. The KCNQ1 signal is shown separately in
white in (C0). Scale bar5 50 mm. (D) The upper middle (M2) turn of a cochlea at W16 immuno-
stained for aceTUBA (red), KCNQ1 (green), and DAPI (blue). Scale bar5 50 mm. (E–G) Higher
magnifications of the outlined areas in (D), showing Reissner’s membrane (E), the marginal cells of
the stria vascularis (F), and the root cells in the outer sulcus (G). Scale bars5 20 mm. (H-H0) The
lower basal turn of a cochlea at W18 immunostained for aceTUBA (red), KCNQ1 (green), and
DAPI (blue). The arrowhead points to Reissner’s membrane. The KCNQ1 signal is shown sepa-
rately in white in (H0). Scale bar5 20 mm. (I-J0) Higher magnifications of the outlined areas in (H).
KCNQ1 signals are shown separately in white in (I0) and (J0). Scale bars5 10 mm. [Color figure can
be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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downregulated by the developing marginal cells and
became exclusively limited to those adjacent cells
[Fig. 10(D)]. Double immunostaining at W18 for
GJE1 and ATP1A1 confirmed the melanocytic origin
of the signal, as no overlap in GJE1 and ATP1A1
was observed [Fig. 10(E,F)].
An overview of the observed spatiotemporal
expression patterns of selected proteins in this study
is presented in Table 2.
DISCUSSION
Are Human Cochlear Melanocytes
Derived from the Neural Crest?
The developmental pattern of melanocyte distribution
observed in the human fetal cochlea closely follows
that of the mouse, where it is generally accepted that
cochlear melanocytes are derived from the neural
crest (Steel et al., 1992; Freyer et al., 2011; Wakaoka
et al., 2013). Therefore, we suggest that the melano-
cytes in the human cochlea are also derived from the
neural crest. However, in all species analyzed so far,
the migratory route taken by melanocytes to arrive in
the cochlea remains unknown. As cochlear develop-
ment in humans progresses slower than in mice (as a
rule of thumb, one day of rodent cochlear develop-
ment corresponds to one week in humans), this
Figure 6 Expression of Na1/K1-ATPase in the human
fetal cochlea. (A) The lower basal turn of a cochlea at
W10.4 immunostained for Na1/K1-ATPase ATP1A1 (red),
melan-A (green), and DAPI (blue). The arrow points to the
location of the future stria vascularis. The ATP1A1 signal
is shown separately in white in (A0). *5 autofluorescent
erythrocytes. Scale bar5 50 mm. (B) The lateral wall in the
lower basal turn of a cochlea at W12 immunostained for
ATP1A1 (red), melan-A (green), and DAPI (blue). The
ATP1A1 signal is shown separately in white in (B0). Scale
bar5 20 mm. (C) The lower basal turn of a cochlea at W14
immunostained for ATP1A1 (red), melan-A (green), and
DAPI (blue). The ATP1A1 signal is shown separately in
white in (C0). Scale bar5 50 mm. (D) Higher magnification
of the developing stria vascularis in (C). The ATP1A1 sig-
nal is shown separately in white in (D0). Scale bar5 20 mm.
(E) The developing stria vascularis in the lower basal turn
of a cochlea at W16 immunostained for ATP1A1 (red),
melan-A (green), and DAPI (blue). The ATP1A1 signal is
shown separately in white in (E0). *5 autofluorescent
erythrocytes. Scale bar5 20 mm. (F) The lower basal turn
of a cochlea at W18 immunostained for ATP1A1 (red),
melan-A (green), and DAPI (blue). The ATP1A1 signal is
shown separately in white in (F0). Scale bar5 50 mm. (G–
H) Higher magnifications of (F), showing the organ of Corti
(G) and epithelial lining of the outer sulcus (H). Scale
bars5 20 mm. (I-J”) Higher magnifications of the stria vas-
cularis in (F), with the separate signals of ATP1A1 (I0 and
J0) and melan-A (I” and J”) shown in white. The arrow in
(I) point to a melan-A1 melanocyte process penetrating
toward the lumen of the cochlear duct. The arrowhead in
(I) points toward an ATP1A11 structure around a melan-
A1 melanocyte cell body. The arrows in (J) point toward
ATP1A11 structures around melan-A1 processes that
encircle a developing capillary. *5 autofluorescent eryth-
rocytes. Scale bars5 20 mm. [Color figure can be viewed in
the online issue, which is available at wileyonlinelibrary.
com.]
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Figure 7 KCNJ10 expression in the human fetal cochlea. (A) The epithelial lining in the lower
basal turn outer sulcus of a cochlea at W16 immunostained for the inwardly-rectifying potassium
channel KCNJ10 (green) and DAPI (blue). The KCNJ10 signal is shown separately in white in
(A0). Scale bar5 50 mm. (B) The lower basal turn of a cochlea at W18 immunostained for sodium/
potassium-transporting ATPase ATP1A1 (red), KCNJ10 (green), and DAPI (blue). The KCNJ10
signal is shown separately in white in (B0). Scale bar5 50 mm. (C) Higher magnification of the
outer sulcus area in (B). The KCNJ10 signal is shown separately in white in (C0). Scale bar5 50
mm. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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Figure 8 Epithelial expression of GJB2 and GJB6 in the cochlear duct. (A-B) The lower basal
turn cochlea at W10.4 immunostained for gap junction proteins GJB2 [(A), green] and GJB6 [(B),
green] and DAPI (blue). GJB2 and GJB6 signals are shown separately in white in (A0) and (B0),
respectively. The bracket outlines the prosensory domain. Scale bars5 50 mm. (C-D) The lower
basal turn cochlea at W12.2 immunostained for GJB2 [(C), green] and GJB6 [(D), green] and
DAPI (blue). GJB2 and GJB6 signals are shown separately in white in (C0) and (D0), respectively.
The bracket outlines the prosensory domain. Scale bars5 50 mm. (E-F) The lower basal turn coch-
lea at W14 immunostained for GJB2 ((E), green) and GJB6 ((F), green) and DAPI (blue). GJB2
and GJB6 signals are shown separately in white in (E0) and (F0), respectively. The bracket outlines
the developing organ of Corti. KO5K€olliker’s organ. Scale bars5 50 mm. (G–H) The lower basal
turn cochlea at W14 immunostained for GJB2 [(G), green] and GJB6 [(H), green] and DAPI (blue).
GJB2 and GJB6 signals are shown separately in white in (G0) and (H0), respectively. The arrow-
heads points to the developing root cells. The bracket outlines the developing of Corti. KO5K€ol-
liker’s organ. Scale bars5 50 mm. (I-J) The lower basal turn cochlea at W14 immunostained for
GJB2 [(I), green] and GJB6 [(J), green] and DAPI (blue). GJB2 and GJB6 signals are shown sepa-
rately in white in (I0) and (J0), respectively. The arrowheads points to the developing root cells. The
bracket outlines the organ of Corti. *5 autofluorescent erythrocytes. Scale bars5 50 mm. [Color
figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
permits a more explicit visualization of developmen-
tal events. Recently, it has been reported that cranial
melanocytes can arise from Schwann cell precursors
migrating together with outgrowing nerves (Ada-
meyko et al., 2009; Adameyko et al., 2012). As
Schwann cell precursors arrive in the cochlea via the
cochlear nerve (Sandell et al., 2014), it is tempting to
propose that melanocytes (precursors) may travel
Figure 9 GJA1 is expressed by type I fibrocytes in the human fetal cochlea. (A) The lower basal
turn of a cochlea at W14 immunostained for the gap junction protein GJA1 (green) and DAPI
(blue). The dotted line outlines the group of spiral ligament fibrocytes expressing GJA1. The GJA1
signal is shown separately in white in (A0). Scale bar5 50 mm. (B) The lower basal turn of a coch-
lea at W18 immunostained for GJA1 (green) and DAPI (blue). The dotted line outlines the group of
spiral ligament fibrocytes expressing GJA1. The GJA1 signal is shown separately in white in (B0).
Scale bar5 50 mm. (C) Hematoxylin and eosin staining of a similar section as shown in (B). The
dotted line represents the area of GJA1-expressing fibrocytes in (B). Scale bar5 50 mm. [Color fig-
ure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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along the same path. However, our data on melano-
cyte migration toward their target location in the
cochlea, which to our knowledge has not been shown
before in such clarity, suggests that cochlear melano-
cytes in humans migrate through the periotic mesen-
chyme from the opposite side. In agreement, several
studies in mice embryos show the presence of neural
crest derivatives or melanocytes near this part of the
otic vesicle around embryonic day 10.5 (Steel et al.,
1992; Freyer et al., 2011; Adameyko et al., 2012;
Wakaoka et al., 2013; Sandell et al., 2014). There-
fore, although the peripheral glial cells in the cochlea
originate from the migratory wave of neural crest
cells from rhombomere 4, we now hypothesize that
cochlear melanocytes originate from a different wave
of neural crest cells, namely those delaminating from
the region at rhombomere 6, at the location of the
developing glossopharyngeal nerve (cranial nerve
IX) and the third pharyngeal arch.
Cochlear Melanocytes, a Major Player in
Syndromic SNHL
Intermediate cells in the stria vascularis were identi-
fied as melanocytes in 1977, although their exact
function was unknown at that time (Hilding and
Ginzberg, 1977). The involvement of cochlear mela-
nocytes in generating the endocochlear potential was
recognized later in a studies with “viable dominant
spotting” mouse mutants, with a mutation in the W
locus (Steel et al., 1987; Steel and Barkway, 1989).
Shortly hereafter, Kit was found to be the gene prod-
uct of the W locus (Chabot et al., 1988; Geissler
et al., 1988), and it was shown to primarily affect the
survival of migratory melanoblasts (Cable et al.,
1995). In humans, KIT mutations can result in the
neurocristopathy (a pathology affecting normal neu-
ral crest development) piebaldism [MIM 172800], a
disorder characterized by areas of skin and hair
devoid of melanocytes. Although most of these
patients have a heterozygous mutation, deafness has
been observed in rare cases of both heterozygous and
homozygous mutations (Spritz and Beighton, 1998;
Kilsby et al., 2013). We show that KIT is expressed
by strial melanocytes in the human fetal cochlea, sug-
gesting that SNHL due to KIT mutations in humans is
caused by mechanisms similar to those in mouse Kit
mutants.
Another neurocristopathy affecting melanocyte
development with pigment abnormalities and SNHL
is the genetically heterogeneous WS, the most com-
mon type of autosomal dominant SNHL in humans.
Its four subtypes are based on clinical symptoms and
multiple causative genes have been identified (Pin-
gault et al., 2010). We show here that in the human
fetal cochlea, MITF expression is confined to mela-
nocytes [Fig. 3(A,C)]. Therefore, it is likely that
cochlear melanocytes are responsible for SNHL in
WS with MITF mutations (causing type IIa WS
[MIM 193510]), and/or PAX3 mutations (a gene reg-
ulating MITF, causative for type I WS [MIM
193500] and type III WS [MIM 148820]). In addition
to MITF, mutations in SOX10 can also cause type II
WS in next to type IVc WS [MIM 613266] (Bondur-
and et al., 2007; Baral et al., 2012), whereas SOX10
has recently also been identified to play a role in
Kallmann syndrome with deafness (KS, [MIM
147950, 244200, 308700, 610628, 612370, and
612702]) (Pingault et al., 2013). SOX10 expression,
however, is not exclusively limited to melanocytes in
the human fetal cochlea [Fig. 3(B)]. We recently
observed additional expression throughout the human
fetal cochlear duct epithelium (Locher et al., 2013)
and in all peripheral glial cells (Locher et al., 2014).
Although it is likely that melanocytes play a major
role in SNHL in WS or KS due to SOX10 mutations,
it cannot be excluded that other SOX101 cell types
in the cochlea are involved as well. Taken together,
the melanocytic expression of MITF, SOX10, and
KIT in the human fetal cochlea help to explain the
Figure 10 GJE1 expression dynamics during cochlear development in the human fetus. (A) The
lower basal turn of a cochlea at W10.4 immunostained for the gap junction protein GJE1 (green)
and DAPI (blue). The GJE1 signal is shown separately in white in (A0). Scale bar5 50 mm. (B) The
developing stria vascularis in the lower basal turn of a cochlea at W12 immunostained for GJE1
(green) and DAPI (blue). The GJE1 signal is shown separately in white in (B0). Scale bar5 10 mm.
(C) The developing stria vascularis in the lower basal turn of a cochlea at W14 immunostained for
GJE1 (green) and DAPI (blue). The GJE1 signal is shown separately in white in (C0). Scale
bar5 50 mm. (D) The developing stria vascularis in the lower basal turn of a cochlea at W16 immu-
nostained for GJE1 (green) and DAPI (blue). The GJE1 signal is shown separately in white in (D0).
Scale bar5 50 mm. (E) The developing stria vascularis in the lower basal turn of a cochlea at W18
immunostained for GJE1 (green) and DAPI (blue). The GJE1 signal is shown separately in white in
(E0). Scale bar5 50 mm. (F) Higher magnification of the area outlined in (E). The GJE1 signal is
shown separately in white in (F0). Scale bar5 20 mm.
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aforementioned hereditary hearing disorders and
underscore the important role of this cochlear cell
type in syndromic SNHL.
The Endocochlear Potential and Its
Relation to Hereditary SNHL
Hearing depends on the highly positive endocochlear
potential, generated by the interplay of various ion
channels and transporters in the cell types of the stria
vascularis [reviewed in (Zdebik et al., 2009; Hibino
et al., 2010)]. The location of these proteins along the
membranes of the different cells of the adult stria
vascularis is depicted in Figure 1(B). Disrupting the
function of any of these proteins (including connexin
proteins) in the stria vascularis or at other locations
in the cochlea where they are thought to be involved
in K1 homeostasis results in immediate SNHL
(Cohen-Salmon et al., 2002; Teubner et al., 2003;
Nin et al., 2008). In many cases of both syndromic
(as mentioned above) and nonsyndromic SNHL, the
endocochlear potential is likely to be affected.
The marginal cells in the stria vascularis express
the voltage-gated potassium channel KCNQ1 (or
KCNE1, [MIM 176261]). Mutations in KCNQ1 cause
the autosomal recessive Jervell and Lange-Nielsen
syndrome [MIM 220400], characterized by SNHL
and cardiac abnormalities (long QT syndrome) (Jer-
vell and Lange-Nielsen, 1957; Neyroud et al., 1997).
In this syndrome, there is an impaired K1 secretion
into the endolymph by the KCNQ1/KCNE1 channel
complex on the apical membranes of the marginal
cells in the stria vascularis, as confirmed in a mouse
model with the homozygous mutants being com-
pletely deaf (Lee et al., 2000). Since a low number of
functional channels still result in normal hearing in
heterozygous patients (Wollnik et al., 1997), it can be
surmized that, to cause deafness, mutations in
KCNQ1 have to inactive the channel complex com-
pletely so that the total K1-secretion is reduced to a
minimum. On the basolateral membranes of the mar-
ginal cells, K1 uptake from the intrastrial space (the
narrow fluid-containing space between the marginal
cells and the melanocytes) is mediated by the
sodium-potassium pump Na1/K1-ATPase (Schulte
and Adams, 1989) and the Na12Cl-K1 cotransporter.
Na1/K1-ATPase is known to be expressed in the
adult human stria vascularis (Weber et al., 2001) and
inhibition of Na1/K1-ATPase directly suppresses the
endocochlear potential in guinea pigs (Kuijpers and
Bonting, 1970; Nin et al., 2008). We found first
expression of KCNQ1 on the luminal membranes of
the marginal cells at W16. At W18, we observed that
the cell processes from the developing marginal cells
Table 2 Spatiotemporal Expression Patterns of Investigated Proteins in the Developing Human Fetal Cochlea
Protein Expression
SLC2A1 (GLUT1) W12–W18: apical membrane of epithelial cells between organ of Corti and
root cells in the outer sulcus (i.e. Hensen’s cells, Claudius cells), capillaries,
erythrocytes
ATP1A1 W10: throughout cochlear duct epithelium
W12: increased expression in lateral wall epithelium
W14–W18: basolateral membranes of marginal cells, basolateral membranes of
inner and outer hair cells, basolateral membranes of epithelial cells in outer sul-
cus, K€olliker’s organ.
KCNQ1 (KVLQT1) W10–W12: basement membrane lateral wall epithelium
W14: Reissner’s membrane, developing root cells in outer sulcus
W16–W18: apical membrane marginal cells, Reissner’s membrane, developing
root cells in outer sulcus
KCNJ10 (Kir4.1) W10–W14: no expression observed
W16–W18: epithelial cells in outer sulcus, including root cells
GJB2 (CX26) W10–W12: increased expression in epithelium of cochlear duct floor, with the
exemption of the prosensory domain
W14–W18: expression in K€olliker’s organ and epithelial cells in outer sulcus
GJB6 (CX30) Identical pattern to GJB2
GJA1 (CX43) W10–W12: no expression observed
W14–W18: increased expression in type I fibrocytes in the spiral ligament
GJE1 (CX23) W10–W12: basolateral membranes of epithelial cells in lateral wall
W14: basolateral membranes of marginal cells, melanocytes
W16–W18: exclusive to melanocytes
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(expressing ATP1A1) and the strial melanocytes
intermingle and form an intricate network together
with the capillaries. The developmental expression of
KCNQ1 and ATP1A1 indicates that both K1 uptake
and secretion could be mediated by marginal cells as
early as W16–W18.
The pivotal role of strial melanocytes in the gener-
ation of the endocochlear potential is to secrete K1
ions into the intrastrial space and hence they express
the inward-rectifying potassium channel KCNJ10
(also known as Kir4.1, [MIM 602208]) (Ando and
Takeuchi, 1999; Eckhard et al., 2012). In contrast to
the potassium channels of the marginal cells, we did
not observe any KCNJ10 expression in strial melano-
cytes up to the last stage we investigated, W18. As
inhibition of this receptor directly suppresses the
endocochlear potential (Nin et al., 2008), it is likely
that the endocochlear potential is not yet generated at
this stage. KCNJ10 is implicated in multiple syn-
dromic disorders with SNHL. Loss-of-function muta-
tions in KCNJ10 cause SESAME syndrome ([MIM
612780], also called EAST syndrome), a disorder
characterized by SNHL, electrolyte imbalance, seiz-
ures, ataxia and mental retardation. Here, the hearing
loss is likely due to disrupted function of strial mela-
nocytes (Scholl et al., 2009). KCNJ10 is also impli-
cated in SNHL in autosomal recessive deafness-4
(DFNB4) with enlarged vestibular aqueduct (EVA)
[MIM 600791], and in autosomal recessive Pendred
syndrome [MIM 274600]. In Pendred syndrome,
SLC26A4 [MIM 605646] mutations account for the
majority of cases (Everett et al., 1997). The dysfunc-
tion of its protein, PENDRIN, results in loss of
KCNJ10 expression in the melanocytes of the stria
vascularis and subsequent loss of the endocochlear
potential (Wangemann et al., 2004; Ito et al., 2014).
However, mutations in KCNJ10 itself have also been
linked directly to Pendred syndrome (Yang et al.,
2009). Interestingly, KCNJ10 has also been described
in the root cells of the outer sulcus, both in the adult
rodent and human cochlea (Jagger et al., 2010; Eck-
hard et al., 2012). Also, the expression pattern of
KCNJ10 that we observed in the outer sulcus during
cochlear development matches the known expression
pattern of PENDRIN in the outer sulcus of the adult
mouse cochlea (Royaux et al., 2003; Wangemann
et al., 2004). This provides a striking link between
the two proteins and could help to explain the etiol-
ogy of SNHL in Pendred syndrome.
Several connexins (Cx, gap junction proteins) are
expressed at various locations in the cochlea and are
thought to be implicated in K1 recycling (Zdebik
et al., 2009; Kelly et al., 2011). Mutations in connex-
ins are a major cause of hereditary SNHL (Smith
et al., 2014). The most frequent causative gene for
nonsyndromatic SNHL is GJB2 (CX26) (Smith et al.,
2014). Although less frequent, mutations in GJB6
(CX30) (Grifa et al., 1999; del Castillo et al., 2002)
and GJA1 (CX43) (Liu et al., 2001; Hong et al., 2010)
have also been linked to SNHL. These gap junction
proteins are thought to play a role in maintaining coch-
lear ion homeostasis and the endocochlear potential,
as shown in Gjb6-deficient mice (Teubner et al.,
2003), by passively recycling K1 ions back to the stria
vascularis. The observed expression in the developing
human cochlea is in support of this model. However,
an interesting note can be made with regard to the
observed glucose transporter (SLC2A1) expression on
the luminal membranes of the outer sulcus cells. As
this part of the cochlea does not have its own vascula-
rization, one could speculate that receptor expression
at this luminal location functions to take up glucose
circulating in the endolymph, suggesting a rather more
active role for these cells with regard to cochlear K1
homeostasis (with a potential role for the Na1/K1-
ATPase?).
Finally, GJE1 has not been previously investigated
in the human cochlea. GJE1 encodes the connexin 23
protein, and should not be confused with CX29/
CX30.2, which used to be called GJE1 but recently
has been renamed to GJC3 [MIM 611925]). In the
developing human fetal cochlea, we observed dynamic
GJE1 expression in the lateral wall, shifting from the
developing marginal cells to the melanocytes between
W14–W16. We speculate that GJE1 could be a suita-
ble candidate gene for non-syndromic SNHL, espe-
cially as a many causes of hereditary deafness remain
presently unknown (Korver et al., 2011).
Maturation of the Lateral Wall and the
Onset of Human Hearing
In many rodent species, development of hearing
extends beyond birth and the onset of hearing occurs
after birth (in an altricial manner). In contrast, hear-
ing development in humans progresses at a much
slower rate, but the cochlea and hearing function are
complete before birth (precocial hearing develop-
ment). Although cochlear size and degree of spirali-
zation differs between species, the morphological
appearance of the various cochlear tissues and struc-
tures as well as the subsequent protein expression
profiles are very similar. Therefore, based on similar-
ities in morphology and protein expression patterns
in adult mammalian cochleas, we conclude that the
human fetal cochlea at W18 demonstrates a nearly
adult phenotype, but that some essential elements for
functionality are still missing. Most notably, strial
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melanocytes do not yet express KCNJ10, basal cells
are immunohistochemically undefined, root cells
have not developed their root-like basolateral proc-
esses, and GJB2 and GJB6 are not yet observed in
the spiral ligament. This implies that the endoco-
chlear potential cannot be generated at this stage and,
therefore, that the human fetus at W18 is still unable
to hear. Although W20 has been proposed by us
(Locher et al., 2013; Locher et al., 2014) and others
(Pujol et al., 1991; Pujol and Lavigne-Rebillard,
1995; Bibas et al., 2008) as the onset of human hear-
ing based on the maturation of the organ of Corti and
the cochlear nerve, it is more likely that hearing com-
mences a few weeks later, which is in line with otoa-
coustic emission measurements (Chabert et al., 2006)
and auditory brainstem responses in preterm infants
(Lary et al., 1985; van Straaten et al., 2001).
In mice and gerbils, the appearance of the endoco-
chlear potential has been observed just prior to their
onset of hearing (Steel and Barkway, 1989; Souter and
Forge, 1998), and coincides with morphological matu-
ration of gap and tight junctions. Even although their
auditory system does not become functional before
birth, the sequence of morphological maturation is
similar to what we observe in human fetuses. In view
of these findings, extrapolation of our observations to
later fetal stages suggests that the endocochlear poten-
tial, and therefore hearing, in the human fetus does not
emerge before the third trimester of pregnancy.
CONCLUSION
We have investigated the complex embryonic develop-
ment of the lateral wall in the human fetal cochlea with
respect to the expression of several genes that are
known to be involved both in syndromic and nonsyn-
dromic SNHL, providing an etiological basis for these
hearing disorders in humans. Although hereditary
SNHL can be caused by specific mutations in various
genes involved in cochlear K1 transport, we would like
to underline the major functional role of melanocytes in
the cochlea and the generation of the endocochlear
potential. We suggest that many cases of hereditary
SNHL can be attributed to a disturbed development or
migration of neural-crest-derived melanocytes.
ACKNOWLEDGMENTS
We would like to thank J. Wiegant and A.M. van der Laan
for technical support, S.B. Blankevoort (anatomical, medi-
cal illustrator of the LUMC) for his work on Figure 1(A),
and the Center for Contraception, Sexuality and Abortion
(CASA) in Leiden and The Hague for the collection of the
human fetal material.
REFERENCES
Adachi N, Yoshida T, Nin F, Ogata G, Yamaguchi S,
Suzuki T, Komune S, et al. 2013. The mechanism under-
lying maintenance of the endocochlear potential by the
K1 transport system in fibrocytes of the inner ear.
J Physiol 591:4459–4472.
Adameyko I, Lallemend F, Aquino JB, Pereira JA, Topilko
P, M€uller T, Fritz N, et al. 2009. Schwann cell precursors
from nerve innervation are a cellular origin of melano-
cytes in skin. Cell 139:366–379.
Adameyko I, Lallemend F, Furlan A, Zinin N, Aranda S,
Kitambi SS, Blanchart A, et al. 2012. Sox2 and Mitf
cross-regulatory interactions consolidate progenitor and
melanocyte lineages in the cranial neural crest. Develop-
ment 139:397–410.
Ando M, Takeuchi S. 1999. Immunological identification
of an inward rectifier K1 channel (Kir4.1) in the interme-
diate cell (melanocyte) of the cochlear stria vascularis of
gerbils and rats. Cell Tissue Res 298:179–183.
Angeli S, Lin X, Liu XZ. 2012. Genetics of hearing and
deafness. Anat Rec (Hoboken) 295:1812–1829.
Baral V, Chaoui A, Watanabe Y, Goossens M, Attie-Bitach
T, Marlin S, Pingault V, et al. 2012. Screening of MITF
and SOX10 regulatory regions in Waardenburg syndrome
type 2. PLoS One 7:e41927.
Bibas A, Liang J, Michaels L, Wright A. 2000. The devel-
opment of the stria vascularis in the human foetus. Clin
Otolaryngol Allied Sci 25:126–129.
Bibas AG, Xenellis J, Michaels L, Anagnostopoulou S,
Ferekidis E, Wright A. 2008. Temporal bone study of
development of the organ of Corti: Correlation between
auditory function and anatomical structure. J Laryngol
Otol 122:336–342.
Bizhanova A, Kopp P. 2010. Genetics and phenomics of
Pendred syndrome. Mol Cell Endocrinol 322:83–90.
Bondurand N, Dastot-Le Moal F, Stanchina L, Collot N,
Baral V, Marlin S, Attie-Bitach T, et al. 2007. Deletions
at the SOX10 gene locus cause Waardenburg syndrome
types 2 and 4. Am J Hum Genet 81:1169–1185.
Cable J, Jackson IJ, Steel KP. 1995. Mutations at the W
locus affect survival of neural crest-derived melanocytes
in the mouse. Mech Dev 50:139–150.
Chabert R, Guitton MJ, Amram D, Uziel A, Pujol R,
Lallemant J-G, Puel J-L. 2006. Early maturation of
evoked otoacoustic emissions and medial olivocochlear
reflex in preterm neonates. Pediatr Res 59:305–308.
Chabot B, Stephenson DA, Chapman VM, Besmer P,
Bernstein A. 1988. The proto-oncogene c-kit encoding a
transmembrane tyrosine kinase receptor maps to the
mouse W locus. Nature 335:88–89.
Cohen-Salmon M, Ott T, Michel V, Hardelin JP, Perfettini
I, Eybalin M, Wu T, et al. 2002. Targeted ablation of
Development of the Human Stria Vascularis 1237
Developmental Neurobiology
connexin26 in the inner ear epithelial gap junction net-
work causes hearing impairment and cell death. Curr Biol
12:1106–1111.
Del Castillo I, Villamar M, Moreno-Pelayo MA, del
Castillo FJ, Alvarez A, Tellerıa D, Menendez I, et al.
2002. A deletion involving the connexin 30 gene in non-
syndromic hearing impairment. N Engl J Med 346:243–
249.
Denoyelle F, Weil D, Maw MA, Wilcox SA, Lench NJ,
Allen-Powell DR, Osborn a H, et al. 1997. Prelingual
deafness: High prevalence of a 30delG mutation in the
connexin 26 gene. Hum Mol Genet 6:2173–2177.
Eckhard A, Gleiser C, Rask-Andersen H, Arnold H, Liu W,
Mack A, M€uller M, et al. 2012. Co-localisation of
K(ir)4.1 and AQP4 in rat and human cochleae reveals a
gap in water channel expression at the transduction sites
of endocochlear K(1) recycling routes. Cell Tissue Res
350:27–43.
Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Heyman
M, Adawi F, et al. 1997. Pendred syndrome is caused by
mutations in a putative sulphate transporter gene (PDS).
Nat Genet 17:411–422.
Freyer L, Aggarwal V, Morrow BE. 2011. Dual embryonic
origin of the mammalian otic vesicle forming the inner
ear. Development 138:5403–5414.
Geissler EN, Ryan MA, Housman DE. 1988. The
dominant-white spotting (W) locus of the mouse encodes
the c-kit proto-oncogene. Cell 55:185–192.
Grifa A, Wagner CA, D’Ambrosio L, Melchionda S,
Bernardi F, Lopez-Bigas N, Rabionet R, et al. 1999.
Mutations in GJB6 cause nonsyndromic autosomal domi-
nant deafness at DFNA3 locus. Nat Genet 23:16–18.
Hibino H, Nin F, Tsuzuki C, Kurachi Y. 2010. How is the
highly positive endocochlear potential formed? The spe-
cific architecture of the stria vascularis and the roles of
the ion-transport apparatus. Pflugers Arch 459:521–533.
Hilding DA, Ginzberg RD. 1977. Pigmentation of the stria
vascularis. The contribution of neural crest melanocytes.
Acta Otolaryngol 84:24–37.
Hilgert N, Smith RJH, Van Camp G. 2009a. Forty-six
genes causing nonsyndromic hearing impairment: Which
ones should be analyzed in DNA diagnostics? Mutat Res
681:189–196.
Hilgert N, Smith RJH, Van Camp G. 2009b. Function and
expression pattern of nonsyndromic deafness genes. Curr
Mol Med 9:546–564.
Hong H-M, Yang J-J, Shieh J-C, Lin M-L, Li M-L, Li S-Y.
2010. Novel mutations in the connexin43 (GJA1) and
GJA1 pseudogene may contribute to nonsyndromic hear-
ing loss. Hum Genet 127:545–551.
Hudspeth AJ. 1989. How the ear’s works work. Nature
341:397–404.
Ito M, Spicer SS, Schulte BA. 1993. Immunohistochemical
localization of brain type glucose transporter in mamma-
lian inner ears: Comparison of developmental and adult
stages. Hear Res 71:230–238.
Ito T, Li X, Kurima K, Choi BY, Wangemann P, Griffith
AJ. 2014. Slc26a4-insufficiency causes fluctuating hear-
ing loss and stria vascularis dysfunction. Neurobiol Dis
66:53–65.
Jagger DJ, Nevill G, Forge A. 2010. The membrane proper-
ties of cochlear root cells are consistent with roles in
potassium recirculation and spatial buffering. J Assoc
Res Otolaryngol 448:435–448.
Jervell A, Lange-Nielsen F. 1957. Congenital deaf-mutism,
functional heart disease with prolongation of the Q-T
interval and sudden death. Am Heart J 54:59–68.
Kammen-Jolly K, Ichiki H, Scholtz AW, Gsenger M,
Kreczy A, Schrott-Fischer A. 2001. Connexin 26 in
human fetal development of the inner ear. Hear Res 160:
15–21.
Kelly JJ, Forge A, Jagger DJ. 2011. Development of gap
junctional intercellular communication within the lateral
wall of the rat cochlea. Neuroscience 180:360–369.
Kelsell DP, Dunlop J, Stevens HP, Lench NJ, Liang JN,
Parry G, Mueller RF, et al. 1997. Connexin 26 mutations
in hereditary non-syndromic sensorineural deafness.
Nature 387:80–83.
Kilsby AJ, Cruwys M, Kukendrajah C, Russell-Eggitt I,
Raglan E, Rajput K, Loshe P, et al. 2013. Homozygosity
for piebaldism with a proven KIT mutation resulting in
depigmentation of the skin and hair, deafness, develop-
mental delay and autism spectrum disorder. Clin Dysmor-
phol 22:64–67.
Kim SH, Kim KX, Raveendran NN, Wu T, Pondugula SR,
Marcus DC. 2009. Regulation of ENaC-mediated sodium
transport by glucocorticoids in Reissner’s membrane epi-
thelium. Am J Physiol Cell Physiol 296:C544–C557.
Kimura RS, Schuknecht HF. 1970. The ultrastructure of the
human stria vascularis. I. Acta Otolaryngol 69:415–427.
Korver AMH, Admiraal RJC, Kant SG, Dekker FW, Wever
CC, Kunst HPM, Frijns JHM, et al. 2011. Causes of per-
manent childhood hearing impairment. Laryngoscope
121:409–416.
Kuijpers W, Bonting SL. 1970. The cochlear potentials. I.
The effect of ouabain on the cochlear potentials of the
guinea pig. Pflugers Arch 320:348–358.
Lary S, Briassoulis G, de Vries L, Dubowitz LM, Dubowitz
V. 1985. Hearing threshold in preterm and term infants
by auditory brainstem response. J Pediatr 107:593–599.
Lavigne-Rebillard M, Bagger-Sj€ob€ack D. 1992. Develop-
ment of the human stria vascularis. Hear Res 64:39–51.
Lee MP, Ravenel JD, Hu RJ, Lustig LR, Tomaselli G,
Berger RD, Brandenburg S a, et al. 2000. Targeted dis-
ruption of the Kvlqt1 gene causes deafness and gastric
hyperplasia in mice. J Clin Invest 106:1447–1455.
Linden Phillips L, Bitner-Glindzicz M, Lench N, Steel KP,
Langford C, Dawson SJ, Davis A, et al. 2013. The future
role of genetic screening to detect newborns at risk of
childhood-onset hearing loss. Int J Audiol 52:124–133.
Liu W, Bostr€om M, Kinnefors A, Rask-Andersen H. 2009.
Unique expression of connexins in the human cochlea.
Hear Res 250:55–62.
Liu W, Glueckert R, Linthicum FH, Rieger G, Blumer M,
Bitsche M, Pechriggl E, et al. 2014. Possible role of gap
junction intercellular channels and connexin 43 in
1238 Locher et al.
Developmental Neurobiology
satellite glial cells (SGCs) for preservation of human spi-
ral ganglion neurons : A comparative study with clinical
implications. Cell Tissue Res 355:267–278.
Liu XZ, Xia XJ, Adams J, Chen ZY, Welch KO, Tekin M,
Ouyang XM, et al. 2001. Mutations in GJA1 (connexin
43) are associated with non-syndromic autosomal reces-
sive deafness. Hum Mol Genet 10:2945–2951.
Locher H, de Groot JCMJ, van Iperen L, Huisman MA,
Frijns JHM, Chuva de Sousa Lopes SM. 2013. Neurosen-
sory development and cell fate determination in the
human cochlea. Neural Dev 8:20.
Locher H, Frijns JHM, van Iperen L, de Groot JCMJ,
Huisman MA, Chuva de Sousa Lopes SM. 2014. Distri-
bution and development of peripheral glial cells in the
human fetal cochlea. B. Sokolowski, ed. PLoS One 9:
e88066.
Morton CC, Nance WE. 2006. Newborn hearing screen-
ing–a silent revolution. N Engl J Med 354:2151–2164.
Neyroud N, Tesson F, Denjoy I, Leibovici M, Donger C,
Barhanin J, Faure S, et al. 1997. A novel mutation in the
potassium channel gene KVLQT1 causes the Jervell and
Lange-Nielsen cardioauditory syndrome. Nat Genet 15:
186–189.
NHSP. 2011. Annual Report NHS Newborn Hearing
Screening Programme, 2010–2011.
Nin F, Hibino H, Doi K, Suzuki T, Hisa Y, Kurachi Y.
2008. The endocochlear potential depends on two K1
diffusion potentials and an electrical barrier in the stria
vascularis of the inner ear. Proc Natl Acad Sci USA 105:
1751–1756.
Patuzzi R. 2011. Ion flow in stria vascularis and the produc-
tion and regulation of cochlear endolymph and the endo-
lymphatic potential. Hear Res 277:4–19.
Pendred V. 1896. Daef-mutism and Goitre. Lancet 148:
532.
Pingault V, Bodereau V, Baral V, Marcos S, Watanabe Y,
Chaoui A, Fouveaut C, et al. 2010. Review and update of
mutations causing Waardenburg syndrome. Hum Mutat
31:391–406.
Pingault V, Ente D, Dastot-Le Moal F, Goossens M, Marlin
S, Bondurand N. 2013. Loss-of-function mutations in
SOX10 cause Kallmann syndrome with deafness. Am J
Hum Genet 92:707–724.
Pujol R, Lavigne-Rebillard M. 1995. Sensory and neural
structures in the developing human cochlea. Int J Pediatr
Otorhinolaryngol 32:S177–S182.
Pujol R, Lavigne-Rebillard M, Uziel A. 1991. Development
of the human cochlea. Acta Otolaryngol Suppl 482:7–12;
discussion 13.
Royaux IE, Belyantseva IA, Wu T, Kachar B, Everett LA,
Marcus DC, Green ED. 2003. Localization and functional
studies of pendrin in the mouse inner ear provide insight
about the etiology of deafness in Pendred syndrome.
J Assoc Res Otolaryngol 4:394–404.
Sandell LL, Butler Tjaden NE, Barlow AJ, Trainor PA.
2014. Cochleovestibular nerve development is integrated
with migratory neural crest cells. Dev Biol 385:200–210.
Schindelin J, Arganda-Carreras I, Frise E, Kaynig V,
Longair M, Pietzsch T, Preibisch S, et al. 2012. Fiji: An
open-source platform for biological-image analysis. Nat
Methods 9:676–682.
Scholl UI, Choi M, Liu T, Ramaekers VT, H€ausler MG,
Grimmer J, Tobe SW, et al. 2009. Seizures, sensorineural
deafness, ataxia, mental retardation, and electrolyte
imbalance (SeSAME syndrome) caused by mutations in
KCNJ10. Proc Natl Acad Sci USA 106:5842–5847.
Schulte BA, Adams JC. 1989. Distribution of immunoreac-
tive Na1,K1-ATPase in gerbil cochlea. J Histochem
Cytochem 37:127–134.
Shearer EA, Smith RJH. 2012. Genetics: Advances in genetic
testing for deafness. Curr Opin Pediatr 24:679–686.
Smith CA, Lowry OH, Wu ML. 1954. The electrolytes of
the labyrinthine fluids. Laryngoscope 64:141–153.
Smith RJ, Shearer AE, Hildebrand MS, van Camp G. 2014.
Deafness and Hereditary Hearing Loss Overview. Gen-
eReviewsTM [Internet] http://www.ncbi.nlm.nih.gov/
books/NBK1434/. Accessed on February 2014.
Souter M, Forge A. 1998. Intercellular junctional matura-
tion in the stria vascularis: Possible association with onset
and rise of endocochlear potential. Hear Res 119:81–95.
Spritz RA, Beighton P. 1998. Piebaldism with deafness:
Molecular evidence for an expanded syndrome. Am J
Med Genet 75:101–103.
Steel KP, Barkway C. 1989. Another role for melanocytes:
Their importance for normal stria vascularis development
in the mammalian inner ear. Development 107:453–463.
Steel KP, Barkway C, Bock GR. 1987. Strial dysfunction in
mice with cochleo-saccular abnormalities. Hear Res 27:
11–26.
Steel KP, Davidson DR, Jackson IJ. 1992. TRP-2/DT, a
new early melanoblast marker, shows that steel growth
factor (c-kit ligand) is a survival factor. Development
115:1111–1119.
Stelma F, Bhutta MF. 2014. Non-syndromic hereditary sen-
sorineural hearing loss: Review of the genes involved.
J Laryngol Otol 128:13–21.
Teubner B, Michel V, Pesch J, Lautermann J, Cohen-
Salmon M, S€ohl G, Jahnke K, et al. 2003. Connexin30
(Gjb6)-deficiency causes severe hearing impairment and
lack of endocochlear potential. Hum Mol Genet 12:13–
21.
van Camp G, Smith RJ. 2014. Hereditary Hearing Loss
Homepage, http://hereditaryhearingloss.org/. Accessed
on February, 2014.
van der Ploeg CPB, Uilenburg NN, Kauffman-de Boer
MA, Oudesluys-Murphy AM, Verkerk PH. 2012. New-
born hearing screening in youth health care in the Nether-
lands: National results of implementation and follow-up.
Int J Audiol 51:584–590.
van Straaten HL, Tibosch CH, Dorrepaal C, Dekker FW,
Kok JH. 2001. Efficacy of automated auditory brainstem
response hearing screening in very preterm newborns.
J Pediatr 138:674–678.
Waardenburg PJ. 1951. A new syndrome combining devel-
opmental anomalies of the eyelids, eyebrows and nose
Development of the Human Stria Vascularis 1239
Developmental Neurobiology
root with pigmentary defects of the iris and head hair and
with congenital deafness. Am J Hum Genet 3:195–253.
Wakaoka T, Motohashi T, Hayashi H, Kuze B, Aoki M,
Mizuta K, Kunisada T, et al. 2013. Tracing Sox10-
expressing cells elucidates the dynamic development of
the mouse inner ear. Hear Res 302:17–25.
Wangemann P, Itza EM, Albrecht B, Wu T, Jabba S V,
Maganti RJ, Lee JH, et al. 2004. Loss of KCNJ10 protein
expression abolishes endocochlear potential and causes
deafness in Pendred syndrome mouse model. BMC Med
2:30.
Weber PC, Cunningham CD, Schulte BA. 2001. Potassium
recycling pathways in the human cochlea. Laryngoscope
111:1156–1165.
WHO. 2014. Fact Sheet No300.
Wollnik B, Schroeder BC, Kubisch C, Esperer HD,
Wieacker P, Jentsch TJ. 1997. Pathophysiological mecha-
nisms of dominant and recessive KVLQT1 K1 channel
mutations found in inherited cardiac arrhythmias. Hum
Mol Genet 6:1943–1949.
Yang T, Gurrola JG, Wu H, Chiu SM, Wangemann P,
Snyder PM, Smith RJH. 2009. Mutations of KCNJ10
together with mutations of SLC26A4 cause digenic non-
syndromic hearing loss associated with enlarged vestibu-
lar aqueduct syndrome. Am J Hum Genet 84:651–657.
Zdebik AA, Wangemann P, Jentsch TJ. 2009. Potassium ion
movement in the inner ear: Insights from genetic disease
and mouse models. Physiology (Bethesda) 24:307–316.
1240 Locher et al.
Developmental Neurobiology
